Oncoinvent has published Phase 1 dosimetry data for Radspherin in [...]
Oncoinvent will present final 24-month follow-up data from its Phase [...]
Oncoinvent has published Phase 1 dosimetry data for Radspherin in [...]
Oncoinvent will present final 24-month follow-up data from its Phase [...]